<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl8" position="anchor"><table frame="hsides" rules="groups"><thead><tr><th>A204 cells</th><th>pPDGFR</th><th>pAKT</th><th>pERK</th><th>pFRS2</th></tr></thead><tbody><tr><td>Control</td><td>1</td><td>1</td><td>1</td><td>1</td></tr><tr><td>Sunitinib alone</td><td>0.264</td><td>0.0845</td><td>1.952</td><td>1.473</td></tr><tr><td>Sunitinib + FGF</td><td>0.337</td><td>0.092</td><td>5.350</td><td>8.069</td></tr><tr><td>Sunitinib + FGF + PD173074</td><td>0.304</td><td>0.071</td><td>0.369</td><td>1.013</td></tr></tbody></table><table-wrap-foot><fn><p>&#8226; FGF activates pFRS2 and pERK in the presence of Sunitinib.</p></fn><fn><p>&#8226; PD173074 blocks FGF-induced pFRS2 and pERK activation.</p></fn></table-wrap-foot></table-wrap>